Lumakelas Tablets 120mg

Lumakelas Tablets 120mg, manufactured by Amgen, contains Sotorasib (YJ code: 4291076F1022, standard: 120mg 1 tablet). This KRAS G12C inhibitor specifically and irreversibly binds to the mutated KRAS G12C protein, locking it in an inactive state to inhibit downstream signaling pathways. It is used to treat adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC).